REGULATION OF AMYLOID-ΒETA TRANSPORTERS BY TRANSTHYRETIN - IMPLICATIONS FOR BRAIN PROTECTION AT THE BLOOD-CEREBROSPINAL FLUID BARRIER

REGULATION OF AMYLOID-ΒETA TRANSPORTERS BY TRANSTHYRETIN - IMPLICATIONS FOR BRAIN PROTECTION AT THE BLOOD-CEREBROSPINAL FLUID BARRIER

Bibliographic Details
Main Authors:	Tiago Gião, Hiroshi Ishikawa, Horst Schroten, Christian Schwerk, Isabel Cardoso
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123008564

Similar Items

In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals
by: Fatemeh Dabbagh, et al.
Published: (2022-08-01)

Protocol to analyze the transmigration efficiency of T. brucei using an in vitro model of the blood-cerebrospinal fluid barrier
by: Alexander Herrmann, et al.
Published: (2022-12-01)

Polar Infection of Echovirus-30 Causes Differential Barrier Affection and Gene Regulation at the Blood–Cerebrospinal Fluid Barrier
by: Marie Wiatr, et al.
Published: (2020-08-01)

Echovirus-30 Infection Alters Host Proteins in Lipid Rafts at the Cerebrospinal Fluid Barrier In Vitro
by: Marie Wiatr, et al.
Published: (2020-12-01)

Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model
by: Alexander Martens, et al.
Published: (2022-01-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Different Involvement of Vimentin during Invasion by <i>Listeria monocytogenes</i> at the Blood–Brain and the Blood–Cerebrospinal Fluid Barriers In Vitro
by: Franjo Banovic, et al.
Published: (2022-10-01)

Effect of Lipopolysaccharide-Induced Inflammatory Challenge on β-Glucuronidase Activity and the Concentration of Quercetin and Its Metabolites in the Choroid Plexus, Blood Plasma and Cerebrospinal Fluid
by: Małgorzata Domżalska, et al.
Published: (2021-07-01)

Blood Cerebrospinal Fluid Barrier Function Disturbance Can Be Followed by Amyloid-β Accumulation
by: Yuji Suzuki, et al.
Published: (2022-10-01)

Transcellular migration of neutrophil granulocytes through the blood-cerebrospinal fluid barrier after infection with <it>Streptococcus suis</it>
by: Quitsch Ulrike, et al.
Published: (2011-05-01)

The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro
by: Ulrike Erb, et al.
Published: (2020-07-01)

Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
by: Tomoya Nakano, et al.
Published: (2022-05-01)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
by: Paolo Morfino, et al.
Published: (2023-04-01)

SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
by: Chiara Stüdle, et al.
Published: (2023-10-01)

Interactions and Signal Transduction Pathways Involved during Central Nervous System Entry by <i>Neisseria meningitidis</i> across the Blood–Brain Barriers
by: Julia Borkowski, et al.
Published: (2020-11-01)

Central Nervous System Stimulants Limit Caffeine Transport at the Blood–Cerebrospinal Fluid Barrier
by: Kei Ikeda-Murakami, et al.
Published: (2022-02-01)

Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study
by: Yüksel Çavuşoğlu, et al.
Published: (2024-01-01)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
by: Gro Gujord Tangen, et al.
Published: (2023-02-01)

Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
by: Katharina Knoll, et al.
Published: (2023-07-01)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
by: Marianna Fontana, et al.
Published: (2023-11-01)

Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
by: Eirik Aaseth, et al.
Published: (2024-04-01)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

Probing cerebrospinal fluid mobility for human brain clearance imaging MRI: water transport across the blood-cerebrospinal fluid barrier and mobility of cerebrospinal fluid in perivascular spaces
by: Matthias J.P. van Osch, et al.
Published: (2022-11-01)

Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency
by: Samar Rahhal, et al.
Published: (2023-12-01)

Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer
by: Ellen Y. Cotrina, et al.
Published: (2020-09-01)

Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
by: Tapiola, T, et al.
Published: (2009)

Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway in Vivo
Published: (2021)

Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway in Vivo
by: Dasari, Anvesh K. R., et al.
Published: (2021)

Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”
by: Samar Rahhal, et al.
Published: (2023-12-01)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
by: Mario Nuvolone, et al.
Published: (2022-12-01)

Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients
by: Qingze Zeng, et al.
Published: (2024-04-01)

Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid
by: Jusung An, et al.
Published: (2024-02-01)

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
by: Alejandra González‐Duarte, et al.
Published: (2020-03-01)

Potential Roles and Functions of Listerial Virulence Factors during Brain Entry
by: Franjo Banović, et al.
Published: (2020-05-01)

From Gene to Protein—How Bacterial Virulence Factors Manipulate Host Gene Expression During Infection
by: Lea Denzer, et al.
Published: (2020-05-01)

PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers
by: Koychev, I, et al.
Published: (2017)

Wild-type Transthyretin Amyloid Deposition in an Ascending Aortic Aneurysm
by: Abbas Hoteit, MD, et al.
Published: (2024-05-01)

Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
by: Carsten Tschöpe, et al.
Published: (2022-04-01)

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01)

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01)